PARK, SEUNG BUMKR,박승범,KOH, MIN SEOBKR,고민섭,KOO, JA YOUNGKR,구자영
申请号：
KR1020130105411
公开号：
KR1020150026487A
申请日:
2013.09.03
申请国别(地区):
KR
年份:
2015
代理人:
摘要：
The purpose of the present invention is to provide novel compounds having isoxazole by central structure as a PPAR gamma selective ligand, a manufacturing method thereof, and a pharmaceutical composition for treating PPAR gamma-related diseases containing the novel compounds or pharmaceutically acceptable salt thereof. The compounds can be applied to treatment of PPAR gamma-related diseases, especially, diabetes as an effective medicine without side effects which an existing TZD-series diabetes medicine has.COPYRIGHT KIPO 2015본 발명은 이속사졸을 중심구조로 갖는 신규 화합물 및 이의 제조방법과, 이속사졸을 중심구조로 갖는 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 PPAR 감마 관련 질병 치료용 약학 조성물을 제공한다.
